A recent study examined the impact of sleep on people who have the GLP1R variant rs10305492 (the first gene in the genotype report)
PMID: 18492290 (This study is OPEN ACCESS if you would like to read it) The scientists in this study tested exendin-4 on two different rodent models of Parkinsons (6-hydroxydopamine and lipopolysaccaride), and they found similar results to the previous study
Tirzepatide, developed by Eli Lilly, is the worlds first dual GLP-1R/GIPR agonist and has shown superior weight loss effects compared to semaglutide
For those seeking transformative results, IV Therapy remains the gold standard
Overall, participants using a GLP-1RA consume too many calories, saturated fat, and sodium, adequate amounts of most B-vitamins, copper, phosphorus, selenium, and zinc and inadequate calcium, iron, magnesium, potassium, vitamin A, C, D, E, K, and choline